Royalty Pharma (RPRX) Non Operating Investment Income (2020 - 2021)
Royalty Pharma's (RPRX) quarterly Non Operating Investment Income came in at $11.8 million in Q3 2021, down 11.6% quarter-over-quarter from $13.3 million in Q2 2021.
Powered by 
Analysis
Royalty Pharma (RPRX) Non Operating Investment Income (2020 - 2021) Analysis & Trends
Royalty Pharma has disclosed Non Operating Investment Income across 2 years of filings, most recently posting $11.8 million for Q3 2021.
- In Q3 2021, Non Operating Investment Income changed N/A year-over-year to $11.8 million; the TTM figure through Sep 2021 stood at $61.1 million (changed N/A YoY), while the FY2020 annual figure was $20.6 million, changed N/A from the prior year.
- Non Operating Investment Income came in at $11.8 million for Q3 2021 at Royalty Pharma, down from $13.3 million in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $20.6 million in Q4 2020 to a low of $11.8 million in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn | -112,930.25 |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - | - |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn | 458,000.00 |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn | - |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | - |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn | - |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - | - |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - | - |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn | - |
| 10 | Metalla Royalty & Streaming | 942.93 Mn | 931.86 Mn | 4.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 11.76 Mn |
| Jun 30, 2021 | 13.30 Mn |
| Mar 31, 2021 | 15.49 Mn |
| Dec 31, 2020 | 20.55 Mn |